Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
One big problem in mechanically ventilated ICU patients is delayed gastric emptying. Delayed
gastric emptying in these patients, causes intolerance and high gastric residual volume (GRV)
that can lead to abdominal distention, vomiting, increased aspiration risk and consequently
increased the length of hospital stay.
In this study, investigators will evaluate Neostigmine's effect in reducing GRV in
mechanically ventilated patients and compare its effect with metoclopramide and Ondansetron
.